{"id":29949,"date":"2017-05-18T12:51:15","date_gmt":"2017-05-18T11:51:15","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=29949"},"modified":"2017-05-18T12:51:15","modified_gmt":"2017-05-18T11:51:15","slug":"beques-col%c2%b7legials-quins-resultats-shan-obtingut","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/","title":{"rendered":"Beques col\u00b7legials: quins resultats s&#8217;han obtingut?"},"content":{"rendered":"<p>Els <a href=\"http:\/\/blog.cofb.cat\/quins-son-els-projectes-becats-a-la-convocatoria-2015-2016\/\" target=\"_blank\" rel=\"noopener\">projectes becats pel COFB durant el curs 2015-2016<\/a>, a trav\u00e9s dels quals es potencia la recerca en l\u2019\u00e0mbit farmac\u00e8utic, s\u00f3n \u201c<strong>L\u2019impacte assistencial de la incorporaci\u00f3 de la Salut M\u00f2bil (mHealth) en la pr\u00e0ctica cl\u00ednica del pacient trasplantat card\u00edac<\/strong>\u201d i el \u201c<strong>Risc de sagnat dels nous anticoagulants orals en comparaci\u00f3 amb acenocumarol en la pr\u00e0ctica cl\u00ednica habitual<\/strong>\u201d. Els membres del Tribunal de Beques van valorar la novetat cient\u00edfica, la multidisciplinarietat, l\u2019impacte social, a m\u00e9s de l\u2019inter\u00e8s professional, el m\u00e8tode i la viabilitat dels treballs.<\/p>\n<p><span style=\"color: #888888;\"><b><a href=\"http:\/\/blog.cofb.cat\/circular-farmaceutica-resultats-beques-col%C2%B7legials-novetats-farmacoterapia\/\" target=\"_blank\" rel=\"noopener\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-29960 alignleft\" alt=\"Portada-ciruclar-farmac\u00e8utica\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/Portada-ciruclar-farmac\u00e8utica.jpg\" width=\"209\" height=\"273\" \/><\/a>A la revista cient\u00edfica del Col\u00b7legi <a href=\"http:\/\/www.cofb.org\/c\/document_library\/get_file?uuid=d1f49f88-e869-4930-9914-d0567f887d73&amp;groupId=10136\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #888888;\">Circular Farmac\u00e8utica Vol. 74, n\u00fam. 4, quart trimestre 2016<\/span><\/a> (PDF, via web institucional) es recull un resum dels treballs que han estat becats (de la p\u00e0gina 5 a la 27).<\/b><\/span><\/p>\n<p>\u201cEl primer \u00e9s un projecte innovador. Si b\u00e9 la convocat\u00f2ria va adre\u00e7ada de manera expl\u00edcita a projectes professionals, el jurat va premiar un treball referit a la posada en marxa i l\u2019avaluaci\u00f3 d\u2019una app o aplicaci\u00f3 m\u00f2bil en el seguiment del pacient card\u00edac trasplantat de l\u2019hospital de Sant Pau de Barcelona. Ens agradin m\u00e9s o menys, les noves tecnologies s\u00f3n cada vegada m\u00e9s imprescindible i un simple m\u00f2bil ha passat a ser l\u2019ordinador personal de molts\u201d explica<strong> Tom\u00e0s Casas\u00edn, membre del Tribunal de beques del COFB i director de la Circular<\/strong>, en l\u2019editorial de la publicaci\u00f3. \u201cL\u2019altre est\u00e0 basat en un estudi del sagnat que produeixen els medicaments anticoagulants cumar\u00ednics comparat amb els nous anticoagulants directes antitrombina o antiXa en la pr\u00e0ctica cl\u00ednica habitual. L\u2019estudi s\u2019ha fet a l\u2019\u00c0rea de Gesti\u00f3 Assistencial del Vall\u00e8s Oriental Central que integra nou equips d\u2019atenci\u00f3 prim\u00e0ria i l\u2019Hospital de Granollers. Aquesta informaci\u00f3 del risc de sagnat en la poblaci\u00f3 real mai no ens la donen els assajos cl\u00ednics pivotals que estableixen uns criteris d&#8217;inclusi\u00f3\u00a0 dels tipus de pacients a tractar\u201d.<\/p>\n<p><strong>Dues de les autores dels projectes becats ens resumeixen quins resultats han obtingut amb l&#8217;ajut de les beques col\u00b7legials<\/strong>. Aquestes s\u00f3n les conclusions dels projectes, que es van presentar a la seu col\u00b7legial el 21 de novembre:<\/p>\n<p><b><i><div class=\"box shadow\">Impacte assistencial de la incorporaci\u00f3 de la Salut M\u00f2bil en la pr\u00e0ctica cl\u00ednica del pacient trasplantat card\u00edac<\/i><\/b><\/p>\n<p><strong>Autors: Anna Feliu Ribera, M\u00aa Eulalia Roig Mingell, M\u00aa Antonia Mangues Bafalluy, Mar Gomis Pastor, Ester Amado Guirado. Hospital de Sant Pau.<\/strong><\/p>\n[caption id=\"attachment_29957\" align=\"alignright\" width=\"277\"]<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/beca1.jpg\"><img decoding=\"async\" class=\" wp-image-29957\" alt=\"beca1\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/beca1.jpg\" width=\"277\" height=\"400\" \/><\/a> Visi\u00f3 del men\u00fa de l\u2019eina m\u00f2bil<br \/>Font: Cicrular Farmac\u00e8utica 74[\/caption]\n<p>El pacient trasplantat card\u00edac (TC) necessita el tractament relacionat amb el trasplantament i altra medicaci\u00f3 per al tractament de les possibles comorbiditats. Aix\u00f2 comporta una complexitat terap\u00e8utica important i el risc d\u2019aparici\u00f3 de problemes relacionats amb el tractament. Entre aquests problemes relacionats amb la medicaci\u00f3, destaca la <b>manca d\u2019adher\u00e8ncia terap\u00e8utica (AT) al tractament immunosupressor (TIS), <\/b>la qual\u00a0\u00e9s\u00a0un dels\u00a0principals factors condicionants de la superviv\u00e8ncia de l&#8217;empelt.<\/p>\n<p>L\u2019objectiu principal de l\u2019estudi era avaluar la millora de l\u2019AT del pacient TC mitjan\u00e7ant la implementaci\u00f3 d&#8217;un programa d&#8217;atenci\u00f3 farmaco-terap\u00e8utica multidisciplin\u00e0ria, multinivell i amb el suport de la tecnologia <i>mHealth<\/i>. Entre els objectius secundaris de m\u00e9s inter\u00e8s hi ha validar l&#8217;<b><i>Eina mHeart <\/i><\/b>que han desenvolupat\u00a0i\u00a0demostrar si el programa implementat es tradueix en una\u00a0millora en la qualitat de vida dels pacients, satisfacci\u00f3 de l&#8217;equip\u00a0i dels pacients,\u00a0i l\u2019impacte del programa en resultats negatius de la medicaci\u00f3, complicacions cl\u00edniques\u00a0i altres\u00a0resultats en salut de la poblaci\u00f3 TC.<\/p>\n<p><strong>Resultats obtinguts? En parla Mar Gomis:<\/strong><\/p>\n<p>El desenvolupament tecnol\u00f2gic d\u2019una eina m\u00f2bil i la seva aplicaci\u00f3 en la pr\u00e0ctica cl\u00ednica comporta assegurar el correcte compliment de la protecci\u00f3 de les dades dels pacients, la seguretat i la qualitat de l\u2019eina mitjan\u00e7ant els organismes competents actuals. Per assegurar la usabilitat de l\u2019eina i que aquesta recull les necessitats b\u00e0siques de la poblaci\u00f3 a la qual va dirigida, s\u2019ha d\u2019involucrar en el desenvolupament als mateixos pacients. D\u2019altra banda, resulta imprescindible la integraci\u00f3 de les eines m\u00f2bil en les institucions sanit\u00e0ries per millorar la transversalitat de la informaci\u00f3 registrada, comoditat del pacient i sostenibilitat de la tecnologia.<\/p>\n<p>Els resultats obtinguts fins al moment, segons una an\u00e0lisi preliminar de les dades, permeten concloure que <b>ens trobem amb xifres superiors de pacients no adherents a la medicaci\u00f3\u00a0 (immunosupressors i altra medicaci\u00f3 concomitant) respecte a la literatura publicada<\/b>.<\/p>\n<p>L&#8217;<i>Eina mHeart <\/i>va ser desenvolupada\u00a0pel servei de farm\u00e0cia i l&#8217;equip de trasplantament card\u00edac per identificar el pacient no adherent, con\u00e8ixer el motiu de\u00a0la manca d&#8217;adher\u00e8ncia i poder intervenir de forma individualitzada. La validaci\u00f3 cl\u00ednica de l&#8217;eina, es va portar a terme mitjan\u00e7ant estudi en 28 pacients trasplantats card\u00edacs de menys d&#8217;un any i mig des del trasplantament. <b>Els resultats preliminars indiquen que es podr\u00e0 validar cl\u00ednicament l&#8217;eina<\/b>.<\/p>\n<p><b>La integraci\u00f3 del farmac\u00e8utic a l\u2019equip cl\u00ednic es presenta com una eina de millora de l\u2019adher\u00e8ncia terap\u00e8utica dels pacients<\/b>. L\u2019<i>Eina mHeart <\/i>\u00e9s un suport per als professionals per detectar pacients no adherents, con\u00e8ixer el perfil de no adher\u00e8ncia i intervenir de forma individualitzada.<\/p>\n<p><b>L\u2019assaig cl\u00ednic, aleatoritzat controlat en 137 pacients trasplantats card\u00edacs d&#8217;un any de seguiment,\u00a0est\u00e0 en curs\u00a0i es preveu que finalitzi el juny d\u2019aquest any 2017.<\/b> Si es confirma que els resultats s\u00f3n positius, la plataforma i el projecte assistencial en si podran ser adaptables a altres patologies cr\u00f2niques prevalents en la nostra \u00e0rea de salut en les que la manca d\u2019adher\u00e8ncia sigui determinant de l\u2019efectivitat del tractament i superviv\u00e8ncia del pacient.<\/p>\n<p><strong>Qu\u00e8 ha suposat per al grup de treball rebre aquesta beca del Col\u00b7legi?<\/strong><\/p>\n<p>Haver apostat per un projecte que implica innovaci\u00f3 mitjan\u00e7ant mHealth amb la rigorositat cient\u00edfica que comporta portar a terme un assaig cl\u00ednic, mostra la implicaci\u00f3 del COFB en la recerca cient\u00edfica de qualitat.<\/p>\n<p>D&#8217;altra banda, destacar que encara que ens trobem\u00a0amb qu\u00e8 el finan\u00e7ament de la investigaci\u00f3 en salut s&#8217;ha redu\u00eft, volem agrair al Col\u00b7legi haver ampliat a tres beques anuals i haver incl\u00f2s la tem\u00e0tica de la innovaci\u00f3 en benefici dels pacients.<\/p>\n<p>Agrair a tots i cadascun dels pacients trasplantats de cor del HSCSP que han participat en l\u2019estudi <i>mHeart<\/i> per la seva contribuci\u00f3 i bona predisposici\u00f3. Sense la seva col\u00b7laboraci\u00f3 i mostres de suport aquest projecte no hauria sigut possible.<strong><\/div><\/strong><\/p>\n<p><b><i><div class=\"box shadow\">Risc de sagnat dels nous anticoagulants orals en comparaci\u00f3 amb els antagonistes de la vitamina K (AVK) en la pr\u00e0ctica cl\u00ednica habitual<\/i><\/b><\/p>\n<p><strong>Autors: Esther Pastor Ram\u00f3n, M del Pilar Mas Lombarte, Carles Pardo Gracia, Al\u00edcia Mart\u00ed Ib\u00e1\u00f1ez, Oriol Rovira Verg\u00e9s, Cristina Morales Navajas.<\/strong><\/p>\n<p>El projecte pretenia <b>determinar la seguretat dels anticoagulants d\u2019acci\u00f3 directa (ACOD) en relaci\u00f3 al risc de sagnat<\/b> respecte al acenocumarol i la warfarina en la pr\u00e0ctica cl\u00ednica habitual.<\/p>\n[caption id=\"attachment_29958\" align=\"aligncenter\" width=\"686\"]<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/beca2.jpg\"><img decoding=\"async\" class=\" wp-image-29958  \" alt=\"beca2\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/beca2.jpg\" width=\"686\" height=\"96\" \/><\/a> Taula Hemorr\u00e0gies segons tractament<br \/>Font: Circular Farmac\u00e8utica 74[\/caption]\n<p><b>Resultats obtinguts?<\/b><strong> En parla Esther Pastor:<\/strong><\/p>\n<p><strong>Els ACOD no van presentar major risc de sagnat respecte els AVK<\/strong>. En l\u2019an\u00e0lisi per tipus d\u2019hemorr\u00e0gia no es van observar difer\u00e8ncies significatives entre cohorts ni per l\u2019hemorr\u00e0gia intracranial ni per la gastrointestinal. Tampoc es van observar difer\u00e8ncies per la gravetat de l\u2019hemorr\u00e0gia (sagnat major i sagnat major no cl\u00ednicament rellevant). Els resultats van seguir la mateixa tend\u00e8ncia quan l\u2019an\u00e0lisi es va fer per pacients na\u00eff i no na\u00eff, no trobant-se difer\u00e8ncies significatives en cap de les variables estudiades. S\u00ed que hem observat que el risc de sagnat en els ACOD s\u2019incrementa amb l\u2019edat i que disminueix a m\u00e9s risc tromboemb\u00f2lic.<\/p>\n<p>L\u2019efic\u00e0cia i la seguretat dels ACOD s\u2019ha estudiat en el context d\u2019assaig cl\u00ednic lluny de traduir-se en el m\u00f3n real. Per aix\u00f2, era un repte pel nostre equip poder confirmar si els resultats dels assajos cl\u00ednics es podien extrapolar a la pr\u00e0ctica cl\u00ednica real.<\/p>\n<p>Pel nostre equip ha estat molt gratificant la col\u00b7laboraci\u00f3 entre atenci\u00f3 prim\u00e0ria i hospital en la cerca de coneixement sobre la seguretat dels medicaments.<b><i><\/div><\/i><\/b><\/p>\n<figure id=\"attachment_29952\" aria-describedby=\"caption-attachment-29952\" style=\"width: 558px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/becats-curs-2015-2016-COFB.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-29952  \" alt=\"becats-curs-2015-2016-COFB\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/becats-curs-2015-2016-COFB-1024x683.jpg\" width=\"558\" height=\"372\" \/><\/a><figcaption id=\"caption-attachment-29952\" class=\"wp-caption-text\">El Tribunal de Beques del COFB i els representants dels projectes becats<\/figcaption><\/figure>\n<p><b>Potser tamb\u00e9 t\u2019interessa:<\/b><\/p>\n<p><a href=\"http:\/\/blog.cofb.cat\/beques-col%C2%B7legials-2014-2015-que-sha-aconseguit\/\">Beques col\u00b7legials 2014-2015: qu\u00e8 s\u2019ha aconseguit?<\/a> (Blog)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Els projectes becats pel COFB durant el curs 2015-2016, a trav\u00e9s dels quals es potencia la recerca en l\u2019\u00e0mbit farmac\u00e8utic, s\u00f3n \u201cL\u2019impacte assistencial de la incorporaci\u00f3 de la Salut M\u00f2bil (mHealth) en la pr\u00e0ctica cl\u00ednica del pacient trasplantat card\u00edac\u201d i el \u201cRisc de sagnat dels nous anticoagulants orals en comparaci\u00f3 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":29952,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2551,2187,2753,1009,2552,354,513,56,2754,844,2755,2756],"class_list":["post-29949","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-acods","tag-adherencia","tag-antagonistes-de-la-vitamina-k","tag-anticoagulants-daccio-directa","tag-avk","tag-beques","tag-beques-collegials","tag-investigacio","tag-mheart","tag-recerca","tag-salut-mobil","tag-tractament-immunosupressor"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Beques col\u00b7legials: quins resultats s&#039;han obtingut?<\/title>\n<meta name=\"description\" content=\"Beques col\u00b7legials: quins resultats s&#039;han obtingut? Curs 2015-2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col\u00b7legials-quins-resultats-shan-obtingut\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beques col\u00b7legials: quins resultats s&#039;han obtingut?\" \/>\n<meta property=\"og:description\" content=\"Beques col\u00b7legials: quins resultats s&#039;han obtingut? Curs 2015-2016\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col\u00b7legials-quins-resultats-shan-obtingut\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-18T11:51:15+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Beques col\u00b7legials: quins resultats s&#8217;han obtingut?\",\"datePublished\":\"2017-05-18T11:51:15+00:00\",\"dateModified\":\"2017-05-18T11:51:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/\"},\"wordCount\":1485,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"ACODS\",\"adher\u00e8ncia\",\"antagonistes de la vitamina K\",\"anticoagulants d\u2019acci\u00f3 directa\",\"AVK\",\"beques\",\"Beques col\u00b7legials\",\"Investigaci\u00f3\",\"mHeart\",\"Recerca\",\"salut m\u00f2bil\",\"tractament immunosupressor\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/\",\"name\":\"Beques col\u00b7legials: quins resultats s'han obtingut?\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2017-05-18T11:51:15+00:00\",\"dateModified\":\"2017-05-18T11:51:15+00:00\",\"description\":\"Beques col\u00b7legials: quins resultats s'han obtingut? Curs 2015-2016\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beques col\u00b7legials: quins resultats s&#8217;han obtingut?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Beques col\u00b7legials: quins resultats s'han obtingut?","description":"Beques col\u00b7legials: quins resultats s'han obtingut? Curs 2015-2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col\u00b7legials-quins-resultats-shan-obtingut\/","og_locale":"ca_ES","og_type":"article","og_title":"Beques col\u00b7legials: quins resultats s'han obtingut?","og_description":"Beques col\u00b7legials: quins resultats s'han obtingut? Curs 2015-2016","og_url":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col\u00b7legials-quins-resultats-shan-obtingut\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2017-05-18T11:51:15+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"7 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Beques col\u00b7legials: quins resultats s&#8217;han obtingut?","datePublished":"2017-05-18T11:51:15+00:00","dateModified":"2017-05-18T11:51:15+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/"},"wordCount":1485,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#primaryimage"},"thumbnailUrl":"","keywords":["ACODS","adher\u00e8ncia","antagonistes de la vitamina K","anticoagulants d\u2019acci\u00f3 directa","AVK","beques","Beques col\u00b7legials","Investigaci\u00f3","mHeart","Recerca","salut m\u00f2bil","tractament immunosupressor"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/","url":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/","name":"Beques col\u00b7legials: quins resultats s'han obtingut?","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#primaryimage"},"thumbnailUrl":"","datePublished":"2017-05-18T11:51:15+00:00","dateModified":"2017-05-18T11:51:15+00:00","description":"Beques col\u00b7legials: quins resultats s'han obtingut? Curs 2015-2016","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/18\/beques-col%c2%b7legials-quins-resultats-shan-obtingut\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Beques col\u00b7legials: quins resultats s&#8217;han obtingut?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Els projectes becats pel COFB durant el curs 2015-2016, a trav\u00e9s dels quals es potencia la recerca en l\u2019\u00e0mbit farmac\u00e8utic, s\u00f3n \u201cL\u2019impacte assistencial de la incorporaci\u00f3 de la Salut M\u00f2bil (mHealth) en la pr\u00e0ctica cl\u00ednica del pacient trasplantat card\u00edac\u201d i el \u201cRisc de sagnat dels nous anticoagulants orals en comparaci\u00f3 [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/29949","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=29949"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/29949\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=29949"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=29949"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=29949"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}